Evidence map›Paper›PMID 35117129›Full record

ReviewTranslational cancer research2019

Angiosarcoma of the breast, the unknown-a review of the current literature.

Emanuela Esposito, Franca Avino, Raimondo di Giacomo, Ivana Donzelli, Ugo Marone, Maria Teresa Melucci, Chiara Rinaldo, Fulvio Ruffolo, Ruggero Saponara, Claudio Siani and 4 more

Abstract readReview
In one paragraph

Review in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Differential diagnosis of primary mesenchymal neoplasms of the breast.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Primary Breast Angiosarcoma: Comparative Transcriptome Analysis.International journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Radiation-induced angiosarcoma: case report.Einstein (Sao Paulo, Brazil) · 2020
    Article
  15. Lymph node involvement in secondary breast angiosarcoma - a case presentation.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emanuela EspositoDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Franca AvinoDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Raimondo di GiacomoDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Ivana DonzelliDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Ugo MaroneDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Maria Teresa MelucciDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Chiara RinaldoDivision of Radiology - Presidio Ospedaliero di Marcianise, Caserta, Italy.
Fulvio RuffoloDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Ruggero SaponaraDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Claudio SianiDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Raffaele TortorielloDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Gerardo BottiScientific Direction, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Massimo RinaldoDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
Alfredo FucitoDepartment of Breast and Thoracic Oncology, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiosarcoma of the breast is one of the rarest malignancies. Breast angiosarcoma can be classified into primary when arising de novo and secondary to chronic lymphoedema or breast irradiation. Molecular pathways involved in angiosarcoma development have not been described clearly, yet some gene point mutations and protein altered expression levels have been detected. So far, their management is based above all on surgery. Hence, further studies starting from the few known key points may help to develop more effective strategies based both on target therapies, together with surgery.

Indexed as

Angiosarcomabreastmesenchymal tumours

Identifiers

PMID35117129
PMCPMC8798946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.